An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B
- 1 February 1998
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 12 (2) , 139-143
- https://doi.org/10.1038/sj.leu.2400905
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: